AVTX

Avalo Therapeutics is a biotechnology company that researches and develops new medicines for rare diseases, particularly those affecting the immune system. Doctors and patients would use these treatments if they become approved by regulators. The company makes money through research grants, partnerships with larger pharmaceutical companies, and potentially from future drug sales if their treatments receive approval.